Subtype
Benign Bone Neoplasm
CI-CAN-00001868Explore in graph →
Non-malignant3 active trials5 evidence items
- NCIt
- C4880
Loading cancer entity…
Subtype
CI-CAN-00001868Explore in graph →
Clinical trials
32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02923011 | Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas | recruiting | Phase 3 | 56 | Matthew BucknorOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT02739555 | Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma(BISPHOO) | terminated | Phase 3 | 15 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT02302651 | Non-invasive Focal Therapy for Osteoid Osteoma | unknown | Phase 2 / Phase 3 | 60 | University of Roma La SapienzaOTHER | 1 | Nov 27, 2014 | clinicaltrials |
| NCT00017927 | A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome |
Data updated 22 days agoSource updated Feb 19, 2025source: clinicaltrials
| completed |
| Phase 3 |
| 10 |
| National Institute of Dental and Craniofacial Research (NIDCR)NIH |
| 1 |
| Mar 4, 2008 |
| clinicaltrials |